Last Updated: August 10, 2026

Litigation Details for CAO Lighting, Inc. v. General Electric Company (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in CAO Lighting, Inc. v. General Electric Company
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation summary and analysis for: CAO Lighting, Inc. v. General Electric Company (D. Del. 2020)

Last updated: July 1, 2026

Litigation summary for CAO Lighting, Inc. v. General Electric Company (1:20-cv-00681)

CAO Lighting, Inc. v. General Electric Company is docketed as 1:20-cv-00681 and centers on asserted patent rights tied to lighting-related technology used or sold by General Electric. The case posture, claim construction trajectory, and infringement/validity defenses are not fully recoverable from the information provided. Because a complete, accurate litigation summary requires verified filings, claims, asserted patent numbers, parties’ briefing, and the court’s dispositions, no reliable content can be produced from the current input.

What is the case caption, court, parties, and docket posture for CAO Lighting v. GE (1:20-cv-00681)?

Answer: The docket identifier provided is 1:20-cv-00681 with parties CAO Lighting, Inc. (plaintiff) and General Electric Company (defendant). A litigation summary requires the court name (district and division), the asserted patent(s), and the current procedural status (for example, motion-to-dismiss stage, Markman schedule, summary judgment, trial, or settlement).

What court division and jurisdiction applies to 1:20-cv-00681?

Answer: Not specified in the provided input.

What patents were asserted in the complaint?

Answer: Not specified in the provided input.

What is the current disposition (dismissal, claim construction order, summary judgment, settlement)?

Answer: Not specified in the provided input.

What patents protect the lighting technology at issue in CAO Lighting v. GE?

Answer: Asserted patent numbers are not provided, so the patent protection landscape for the asserted subject matter cannot be stated accurately.

Which patent claims were alleged to be infringed?

Answer: Not provided.

What infringement theories were pleaded (literal infringement, doctrine of equivalents, induced/contributory)?

Answer: Not provided.

What validity challenges were raised (anticipation, obviousness, indefiniteness, written description/enablement)?

Answer: Not provided.

What motions were filed in CAO Lighting, Inc. v. General Electric (1:20-cv-00681)?

Answer: Motion practice specifics cannot be summarized without the docket entries and briefing.

Were there claim construction (Markman) motions?

Answer: Not provided.

Were there motions to dismiss (Rule 12(b)(6) or 35/transfer)?

Answer: Not provided.

Were there summary judgment motions?

Answer: Not provided.

Did the case include discovery disputes or protective order filings?

Answer: Not provided.

How did the court rule on claim construction in CAO Lighting v. GE?

Answer: Claim construction rulings cannot be summarized without the Markman order(s) and claim chart materials.

What terms were construed?

Answer: Not provided.

Did the constructions narrow infringement or strengthen validity positions?

Answer: Not provided.

What infringement and non-infringement arguments did GE raise?

Answer: Parties’ infringement arguments are not available in the input.

How did GE challenge product identification or mapping to claim elements?

Answer: Not provided.

How did GE address willfulness, damages, and notice?

Answer: Not provided.

What validity defenses did GE assert?

Answer: Validity positions are not available in the input.

What prior art was cited (patents, publications, sales offers)?

Answer: Not provided.

What grounds were pursued (35 USC 102/103, 112)?

Answer: Not provided.

Was there a Paragraph IV or Hatch-Waxman angle in 1:20-cv-00681?

Answer: The litigation summary cannot determine whether the case is tied to Orange Book listings, ANDA/505(b)(2), or Hatch-Waxman procedures because the asserted patents and factual context are not provided.

Does the case involve FDA-regulated drug products?

Answer: Not provided.

Does the case involve lighting devices or components outside Hatch-Waxman?

Answer: Not provided.

What damages and remedies were sought by CAO Lighting?

Answer: Remedies sought (injunction, damages period, enhanced damages, attorneys’ fees, costs) are not specified in the provided input.

Were attorneys’ fees requested under 35 USC 285?

Answer: Not provided.

Was injunctive relief sought under 35 USC 283?

Answer: Not provided.

Did the case settle? If so, what were the settlement terms or stipulations?

Answer: No settlement facts or docket outcomes are provided, so settlement terms cannot be stated.

Was there a consent judgment, dismissal with prejudice, or voluntary dismissal?

Answer: Not provided.

Were there confidential settlement terms affecting enforceability going forward?

Answer: Not provided.

How strong is CAO Lighting’s patent estate versus GE’s defenses (litigation-strength analysis)?

Answer: A litigation-strength assessment requires the asserted patents, claim scope, prosecution history, prior art landscape, and the court’s rulings (if any). None of these elements are included.

What do asserted claim limitations suggest about infringement probability?

Answer: Not provided.

What do validity challenges suggest about outcome risk?

Answer: Not provided.

Key timeline of CAO Lighting v. GE (1:20-cv-00681)

Answer: A timeline cannot be produced from the provided input. A usable timeline requires filing date(s), service date, amended complaint(s), answer date, claim construction schedule, dispositive motion dates, and hearing/trial dates or orders.

Key takeaways

  • The docket identifier and party names are provided, but the asserted patent(s), court, and procedural posture are not included, preventing an accurate litigation summary and analysis.
  • No reliable information can be generated about claim construction, motions, defenses, damages, or settlement outcomes without verified docket content.

FAQs

  1. What is the complaint filing date for CAO Lighting, Inc. v. General Electric Company (1:20-cv-00681)?
    Not provided.

  2. Which patents did CAO Lighting assert against GE in 1:20-cv-00681?
    Not provided.

  3. Did GE file a motion to dismiss or transfer venue in 1:20-cv-00681?
    Not provided.

  4. Has the court issued claim construction or summary judgment orders in 1:20-cv-00681?
    Not provided.

  5. What was the final outcome of CAO Lighting v. GE (dismissal, settlement, or trial verdict)?
    Not provided.

References

  1. Case docket: CAO Lighting, Inc. v. General Electric Company, No. 1:20-cv-00681.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.